Alzheimer's disease: the amyloid hypothesis and the Inverse Warburg effect

被引:115
作者
Demetrius, Lloyd A. [1 ,2 ]
Magistretti, Pierre J. [3 ,4 ]
Pellerin, Luc [5 ]
机构
[1] Harvard Univ, Dept Organism & Evolut Biol, Cambridge, MA 02138 USA
[2] Max Planck Inst Mol Genet, D-14195 Berlin, Germany
[3] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia
[4] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Neuroenerget & Cellular Dynam, Lausanne, Switzerland
[5] Univ Lausanne, Dept Physiol, Lab Neuroenerget, Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
age-related disease; mitochondrial dysregulation; metabolic alteration; the Inverse Warburg effect; inverse cancer comorbidity; AEROBIC GLYCOLYSIS; NEURONAL-ACTIVITY; ASTROCYTES; CANCER; BRAIN; METABOLISM; EXPRESSION; ENZYME; PHOSPHORYLATION; OVEREXPRESSION;
D O I
10.3389/fphys.2014.00522
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Epidemiological and biochemical studies show that the sporadic forms of Alzheimer's disease (AD) are characterized by the following hallmarks: (a) An exponential increase with age; (b) Selective neuronal vulnerability; (c) Inverse cancer comorbidity. The present article appeals to these hallmarks to evaluate and contrast two competing models of AD: the amyloid hypothesis (a neuron-centric mechanism) and the Inverse Warburg hypothesis (a neuron-astrocytic mechanism). We show that these three hallmarks of AD conflict with the amyloid hypothesis, but are consistent with the Inverse Warburg hypothesis, a bioenergetic model which postulates that AD is the result of a cascade of three events mitochondrial dysregulation, metabolic reprogramming (the Inverse Warburg effect), and natural selection. We also provide an explanation for the failures of the clinical trials based on amyloid immunization, and we propose a new class of therapeutic strategies consistent with the neuroenergetic selection model.
引用
收藏
页数:20
相关论文
共 74 条
[1]   Energy-Efficient Action Potentials in Hippocampal Mossy Fibers [J].
Alle, Henrik ;
Roth, Arnd ;
Geiger, Joerg R. P. .
SCIENCE, 2009, 325 (5946) :1405-1408
[2]  
[Anonymous], 2002, BIOENERGETICS
[3]   An energy budget for signaling in the grey matter of the brain [J].
Attwell, D ;
Laughlin, SB .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (10) :1133-1145
[4]   Ketogenic diets: An historical antiepileptic therapy with promising potentialities for the aging brain [J].
Balietti, Marta ;
Casoli, Tiziana ;
Di Stefano, Giuseppina ;
Giorgetti, Belinda ;
Aicardi, Giorgio ;
Fattoretti, Patrizia .
AGEING RESEARCH REVIEWS, 2010, 9 (03) :273-279
[5]   Mitochondria take center stage in aging and neurodegeneration [J].
Beal, MF .
ANNALS OF NEUROLOGY, 2005, 58 (04) :495-505
[6]   Role of the Glyoxalase System in Astrocyte-Mediated Neuroprotection [J].
Belanger, Mireille ;
Yang, Jiangyan ;
Petit, Jean-Marie ;
Laroche, Thierry ;
Magistretti, Pierre J. ;
Allaman, Igor .
JOURNAL OF NEUROSCIENCE, 2011, 31 (50) :18338-18352
[7]   Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses [J].
Bertram, Lars ;
Tanzi, Rudolph E. .
NATURE REVIEWS NEUROSCIENCE, 2008, 9 (10) :768-778
[8]  
Blass JP, 2000, ANN NY ACAD SCI, V924, P170
[9]   Glycolysis: a bioenergetic or a survival pathway? [J].
Bolanos, Juan P. ;
Almeida, Angeles ;
Moncada, Salvador .
TRENDS IN BIOCHEMICAL SCIENCES, 2010, 35 (03) :145-149
[10]   Age-related transcriptional changes in gene expression in different organs of mice support the metabolic stability theory of aging [J].
Brink, Thore C. ;
Demetrius, Lloyd ;
Lehrach, Hans ;
Adjaye, James .
BIOGERONTOLOGY, 2009, 10 (05) :549-564